Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
Cardiovascular Respiratory Sleep Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
ESC Heart Fail. 2021 Oct;8(5):4037-4047. doi: 10.1002/ehf2.13492. Epub 2021 Jun 28.
Relationships between cardiac acoustic biomarkers (CABs) measured by acoustic cardiography and clinical outcomes have been reported in heart failure (HF) patients. However, no studies have investigated the temporal change of CABs and the corresponding changes in HF status. The purpose of this study was to assess whether the temporal changes of CABs in patients with acute decompensated heart failure (ADHF) reflect changes in cardiac function and status.
Sixty ADHF patients were enrolled prospectively. CABs and echocardiography data were collected at admission, before discharge, and at the first clinic visit. CABs included electromechanical activation time (EMAT); the time interval from Q wave onset on electrocardiography to the first heart sound (S1), QoS2; the time interval from Q wave onset on electrocardiography to the second heart sound (S2); and third heart sound (S3) and fourth heart sound (S4) intensities, defined as the peak-to-peak amplitudes of S3 and S4. EMATc (EMAT/RR) (P = 0.001), S3 intensity (P < 0.001), and S4 intensity (P < 0.001) were significantly decreased, and QoS2 (P = 0.005) was significantly increased from admission to discharge. The change in S3 intensity was significantly correlated with that of E/A (ρ = 0.571, P < 0.001), and the extended QoS2 was also significantly correlated with the increase in the stroke volume index (ρ = 0.383, P = 0.004).
Some CABs in ADHF patients changed significantly in the normal direction throughout the treatment course and could be useful biomarkers in ADHF management.
心脏声学生物标志物(CAB)与临床结局的关系已在心力衰竭(HF)患者中进行了报道。然而,尚无研究探讨 CAB 的时间变化及其与 HF 状态的相应变化。本研究旨在评估急性失代偿性心力衰竭(ADHF)患者 CAB 的时间变化是否反映了心脏功能和状态的变化。
前瞻性纳入 60 例 ADHF 患者。入院时、出院前和首次就诊时采集 CAB 和超声心动图数据。CAB 包括机电激活时间(EMAT);心电图 Q 波起点至第一心音(S1)、QoS2 的时间间隔;心电图 Q 波起点至第二心音(S2)的时间间隔;第三心音(S3)和第四心音(S4)强度,定义为 S3 和 S4 的峰峰值幅度。EMATc(EMAT/RR)(P=0.001)、S3 强度(P<0.001)和 S4 强度(P<0.001)显著降低,而 QoS2 从入院至出院显著增加(P=0.005)。S3 强度的变化与 E/A 的变化显著相关(ρ=0.571,P<0.001),扩展 QoS2 与每搏量指数的增加也显著相关(ρ=0.383,P=0.004)。
ADHF 患者的一些 CAB 在整个治疗过程中朝着正常方向发生了显著变化,可能是 ADHF 管理中的有用生物标志物。